ARWR
ARROWHEAD PHARMA
Health Care·Biotechnology·UNITED STATES
$87.47
MCap $12.4B
as of 2026-08-20
Total
B2w
Fund
D2w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.66
Sentiment 84.7%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$87.47
Adaptive Mean
$88.62
-1.15 vs mean
Adaptive σ
0.87
MIDOS BB
$86.87 – $90.37
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
-0.15
ROE
-55.2%
Z -0.54
Rev Gr
171.0%
Z -0.98
EPS Gr
—
Z +0.31
OPM Gr
370.2%
Z —
FCF Yld
-0.4%
Z +0.05
EPS Surp
-0.1%
Z +0.06
EPS 3mo Δ
-745.2%
Z +0.21
Fwd P/E
-17.97
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
5.66
Q6M
4.92
Q12M
13.30
MA 30/100
1.082
Bullish (MA30 > MA100)
α (Jensen)
0.5540
β (12M)
1.47
σ (12M)
0.638
Divergence — Fundamentals vs Momentum
Z Percentile
24%
Q Percentile
99%
Divergence
-75.5
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
24.9
RS Pctl
83%
RS Decile
D9
Persistence
2w
at grade B
Options / OI Analysis
as of 2026-08-21
OI Center
$82.43
-5.3% from spot
Max Pain
$75.00
PCR (OI)
0.58
neutral
Skew
-0.24
OI Composite
0
neutral
Direction
bearish